LEXARIA BIOSCIENCE CORP. — Earnings

Most recent reported period: FY2026 (Q1) (filed for period ending 2026-02-28) · sourced from SEC EDGAR

Next earnings (estimated): Sat, May 30, 2026 ~31 days away. Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2026-02-28$20K↓-88.5%$-1M↑+46.6%-7259.5%
2025-11-30$0↓-100.0%$-2M↑+41.0%
2025-08-31$174K↑+107.1%
2025-05-31$174K↑+107.1%$-4M↓-112.7%-2155.4%
2025-02-28$174K↑+20.0%$-3M↓-317.7%-1581.0%
2024-11-30$184K↑+21.6%$-3M↓-129.3%-1463.0%
2024-08-31$84K↑+831.7%
2024-05-31$84K↑+8.1%$-2M↑+24.9%-2074.9%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2026 (Q1)

Revenue
$20K
↓-88.5% -$154K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 68 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+0.0pts
100.0%
Operating Margin↓-5678.5pts
-7259.5%
Net Margin↓-5690.6pts
-7249.9%

Go deeper